20/20 Biolabs, Inc.·4

Mar 4, 5:48 PM ET

Cohen Jonathan M 4

4 · 20/20 Biolabs, Inc. · Filed Mar 4, 2026

Insider Transaction Report

Form 4
Period: 2026-03-03
Cohen Jonathan M
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Stock Option

    [F1]
    2026-03-03+352,936352,936 total
    Exercise: $3.39Exp: 2036-03-03Common Stock (352,936 underlying)
Footnotes (1)
  • [F1]On March 3, 2026, the Reporting Person was granted a stock option for the purchase of 352,936 shares of common stock, which shall vest in equal quarterly installments over the following four (4) years, subject to the Reporting Person's continuous service to the Issuer.
Signature
/s/ Jonathan Cohen|2026-03-04

Documents

1 file
  • 4
    ownership.xmlPrimary